Skip to content

Large Language Models for Non-Coding RNA Biomarker Discovery in Breast Cancer.

2026 · Methods in molecular biology · Vol 3037, pp. 159-172 · 0 citations
Medicine

TL;DR

This chapter explores the integration of LLMs with ncRNA biology, focusing on circRNAs, snoRNAs, and piRNAs in BC, and proposes a computational framework for biomarker identification.

View source

Similar papers

Review Open access Sep 2026

Machine learning approaches for cancer prognosis and diagnosis via non-coding RNA: a comprehensive review

This review critically evaluates ML-driven frameworks for cancer diagnosis and prognosis across four ncRNA subclasses, namely miRNAs, lncRNAs, circRNAs, and piRNAs, while also acknowledging the biophysical and thermodynamic models that reinforce ncRNA bioinformatics.

Md Shafayet Hossain, Yi-ping Phoebe Chen · 0 citations
Review Open access Oct 2026

Exploring non-coding RNAs in Prostate Cancer: from Biomarkers to Therapeutic Strategies

Prostate cancer (PCa) is the second most prevalent malignancy and a leading cause of can- cer-related mortality in males worldwide. Despite advancements in therapeutic strategies, such as radical prostatectomy, radiotherapy, androgen deprivation therapy (ADT), and chemotherapy, treatment outcomes for metastatic castrat...

Dharanidharan Dhanabalan, N. Shanmugam · 0 citations
Review Open access Sep 2026

Multi-omics and molecular biomarkers in breast cancer: a comprehensive review of diagnostic, prognostic, and predictive applications.

An overview of recent progress in multi-omics approaches is provided and significant miRNA-, lncRNA-, and exosome-related biomarkers associated with the initiation, progression, and therapeutic response of breast cancer are emphasized.

Kamyar Bagheri, Amirhossein Saberi, Maryam Zand et al. · 0 citations
Open access Sep 2026

Integrative multi-omics profiling and machine learning reveal enhancer RNA signatures for early detection and prognostic stratification in breast cancer

These findings establish eRNAs as a complementary noncoding layer to conventional messenger RNA classifiers, with clinical potential for breast cancer risk stratification, therapeutic guidance, and early detection.

Jun-Huan Xia, Jing-Wen Tian, Yu-Ting Cao et al. · 0 citations
Review 2026

Emerging biomarkers in breast cancer.

C. J. Vellan, Kartthigeen Tamel Selvan, J. J. Jayapalan · 0 citations
Open access Aug 2026

Long Noncoding RNAs (lncRNAs) as Biomarkers of Prognosis in TNBC and Non-TNBC Breast Cancer Patients

This computational study identifies several candidate lncRNAs associated with clinical outcomes in breast cancer, which should be interpreted as preliminary candidates, which require future validation and functional studies to determine their biological roles and evaluate their potential as prognostic biomarkers.

M. Acencio, Xin-Hui Wang, Flavia R. Rotea Mangone et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.